Pacer Advisors
IONS icon

Pacer Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Pacer Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50K Buy
+629
New +$47.3K ﹤0.01% 2040
2024
Q3 		– Sell
-960
Closed -$45.8K – 2622
2024
Q2 		$45.8K Sell
960
-11
-1% -$451 ﹤0.01% 3213
2024
Q1 		$42.1K Buy
+971
New +$46.3K ﹤0.01% 3238
2021
Q2 		– Sell
-1,471
Closed -$66K – 1476
2021
Q1 		$66K Sell
1,471
-1,410
-49% -$78.6K ﹤0.01% 1398
2020
Q4 		$163K Buy
2,881
+1,080
+60% +$53.8K ﹤0.01% 1267
2020
Q3 		$85K Buy
+1,801
New +$100K ﹤0.01% 1272
2019
Q3 		– Sell
-20,333
Closed -$1.31M – 1187
2019
Q2 		$1.31M Buy
+20,333
New +$1.44M 0.03% 699
2019
Q1 		– Sell
-12,106
Closed -$654K – 754
2018
Q4 		$654K Buy
12,106
+6,187
+105% +$316K 0.02% 118
2018
Q3 		$305K Buy
+5,919
New +$278K 0.01% 949
2018
Q1 		– Sell
-1,982
Closed -$100K – 1085
2017
Q4 		$100K Sell
1,982
-13,979
-88% -$767K 0.01% 960
2017
Q3 		$809K Buy
15,961
+2,002
+14% +$105K 0.07% 403
2017
Q2 		$710K Buy
13,959
+922
+7% +$42.9K 0.07% 409
2017
Q1 		$524K Buy
13,037
+2,085
+19% +$93.6K 0.06% 462
2016
Q4 		$524K Buy
10,952
+605
+6% +$23.9K 0.07% 376
2016
Q3 		$379K Buy
10,347
+710
+7% +$22.2K 0.06% 484
2016
Q2 		$225K Buy
9,637
+8,049
+507% +$260K 0.04% 731
2016
Q1 		$64K Buy
1,588
+79
+5% +$3.21K 0.01% 746
2015
Q4 		$93K Buy
+1,509
New +$81.4K 0.02% 623

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pacer Advisors's IONS Position: Q2 2026 in Review

Pacer Advisors opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 629 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #2040 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in IONS as recently as Q2 2024.

Pacer Advisors first reported a position in IONS in Q4 2015 and has held it in 18 quarters since. The position peaked at $1.31M in Q2 2019. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Pacer Advisors held 629 shares of Ionis Pharmaceuticals worth $50K as of Q2 2026.
  • Ionis Pharmaceuticals was a new Pacer Advisors position in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2040 holding.
  • Pacer Advisors first reported a position in Ionis Pharmaceuticals in Q4 2015 and has held it in 18 quarters since.
  • Pacer Advisors's Ionis Pharmaceuticals position peaked at $1.31M in Q2 2019.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.